36th Annual General Meeting of the company to be held on Wednesday, 24th September, 2025 at 11.00 a.m. through VC/OAVM
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited (BSE: 539561) has notified that its 36th Annual General Meeting will be held on Wednesday, September 24, 2025 at 11:00 a.m. through video conferencing (VC/OAVM), with no physical attendance. The agenda includes adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, re-appointment of Mr. Mansoor Abdul Vahab (DIN: 02882381) as a Non-Executive Director (retiring by rotation), and appointment of Ms. Riddhi Shah as Secretarial Auditor for a 5-year term (FY 2025-26 to FY 2029-30) with proposed annual fees of Rs. 50,000 plus taxes. Remote e-voting via NSDL will be open from September 21 to September 23, 2025, with the cut-off date for voting eligibility set as September 17, 2025. The Annual Report and AGM notice are available on the company's website at www.remlife.com.
This is a routine AGM notice with standard agenda items. No material financial or strategic decisions are being put to shareholders beyond the usual adoption of accounts, a rotational director re-appointment, and a regulatory secretarial auditor appointment. Investors should review the FY 2024-25 audited results in the linked annual report; the stock is unlikely to see meaningful price movement solely from this notice.